Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Very Low Dose Add-on Prednisolone in Newly Diagnosed Rheumatoid Arthritis
NCT07252271Phase 4Not yet recruiting
- Sponsor
- The Chinese University of Hong Kong
- Start
- Dec 2025
- Primary completion
- Jun 2028
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of prednisolone in rheumatoid arthritis (RA), sponsored by The Chinese University of Hong Kong. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
prednisolone
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT07252271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07252271.